Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Revenue: 2018-2024

Historic Revenue for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to $10.9 million.

  • Avidity Biosciences' Revenue rose 434.03% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 106.27%. This contributed to the annual value of $10.9 million for FY2024, which is 13.99% up from last year.
  • Per Avidity Biosciences' latest filing, its Revenue stood at $10.9 million for FY2024, which was up 13.99% from $9.6 million recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Revenue ranged from a high of $10.9 million in FY2024 and a low of $6.8 million during FY2020.
  • Over the past 3 years, Avidity Biosciences' median Revenue value was $9.6 million (recorded in 2023), while the average stood at $9.9 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 192.67% in 2020, then fell by 1.09% in 2022.
  • Avidity Biosciences' Revenue (Yearly) stood at $6.8 million in 2020, then spiked by 37.41% to $9.3 million in 2021, then decreased by 1.09% to $9.2 million in 2022, then grew by 3.64% to $9.6 million in 2023, then rose by 13.99% to $10.9 million in 2024.